West Pharmaceutical Services, Inc. announces the opening of a new purpose-built analytical laboratory building housing approximately 80 team members near its manufacturing site in Stolberg on July 17, 2025.
Exton, PA, July 17, 2025 - West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that it opened a new purpose-built analytical laboratory building housing approximately 80 team members near its manufacturing site in Stolberg on July 17, 2025.
" We are excited to announce the opening of our new, state of the art, laboratory, which will allow us to broaden our range of services to meet the growing needs of our customers for analytical chemistry and microbiological testing,” expressed Kathy dePadua, Senior Vice President, Chief Quality and Regulatory Officer at West. “As a market leader, West recognizes the importance of staying agile in response to the continuously evolving regulatory landscape in our industry, and we look forward to continuing to support our customers, as we collaborate to provide injectable medicines to patients across the globe."
The new laboratory expands West’s capabilities to support increased manufacturing needs with finished goods release testing, incoming inspections, and special projects such as new method validations and testing automation. In addition to analytical chemistry testing, specialized microbiological and particulate testing to support West’s manufacturing sites, the new lab also provides West with the additional capacity to offer specialized contract testing for its customers. The building was designed to accommodate future expansion to enable West to meet increasing testing demands for volume, new technology, automation, and regulatory requirements, including EU GMP Annex 1.
Photo Caption: Left to Right: Nadine Leonhardt, Mayor of Eschweiler; Matthias Bahr, VP QA Global Laboratory, West; Kathy dePadua, Senior Vice President, Chief Quality and Regulatory Officer, West; Mrs. Iris Bavaj, VP QA Containment & Managing Director West Germany; Patrick Haas Mayor of Stolberg
About West Germany
West Pharmaceutical Services Deutschland GmbH & Co. KG, founded in 1960 as Pharma-Gummi Hans Wimmer in Vicht, is a subsidiary of West Pharmaceutical Services, Inc., a U.S. corporation.
Today, West employs over 1,460 team members in Germany. The Eschweiler site specializes in the manufacturing of elastomer products for the pharmaceutical industry and the Stolberg site specializes in highly automated metal, plastic, and combination seal manufacturing, as well as cleanroom moulding and assembly.
The Kiefernweg campus located close the manufacturing sites includes an office building and innovation and technology centre for research and development of pharmaceutical packaging components and systems for injectable drugs.
The analytical laboratory situated in Stolberg, supports both manufacturing sites with finished goods release testing, incoming inspection, and special projects such as new method validations. In addition to supporting the local manufacturing sites, the lab performs special microbiological and particulate testing for special projects and requests globally.
West’s tool shop in Stolberg provides tooling products and services for West manufacturing sites globally.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.
Primary Media Contact:
Catriona Kennedy
Director, Regional & Corporate Communications
+353 (0) 87 2920357
[email protected]
Secondary Media Contact
Eileen Falchetta
Sr. Manager, External Communications
484-354-7857
[email protected]
More information
